Advertisement

ASRS 2023: RETINAL VASCULAR DISEASE

Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD

Aug 08, 2023

REFERENCES & ADDITIONAL READING

Source: Patel JI, et al. Intravitreal Aflibercept 8 mg Injection in Patients With Neovascular Age-Related Macular Degeneration: 48-week Results From the Phase 3 PULSAR Trial. Wet AMD Symposium 1. ASRS 41st Annual Meeting 2023; July 28-August 1, 2023: Seattle.

ABOUT THE EXPERTS

  • Jignesh I. Patel, MD

    Jignesh I. Patel, MD
    Attending Retinal Specialist
    Colchester Hospitals University Foundation Trust
    England

    Jignesh I. Patel, MD, has indicated to Physician’s Weekly that he serves as a consultant for Bayer and on a speaker’s bureau for Roche.

Advertisement
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters